CIK 0001447028 · Non-accelerated filer<br>Smaller reporting company
Arbutus Biopharma Corp
Sign in to watch- Ticker
- ABUS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- EIN
- 980597776
- Phone
- 604-419-3200
- Business address
- 701 VETERANS CIRCLE, WARMINSTER, PA, 18974
- Former names
- TEKMIRA PHARMACEUTICALS CORP, TEKMIRA PHARMACEUTICALS Corp
- 4 Derivatives Options or other derivatives
- 4 Grant or award General Counsel and CCO acquired 95,100 shares (grant or award)
- 4 Planned sale Chief Medical Officer sold 4,358 shares at $2.31 ($10,078)
- 4 Planned sale Chief Financial Officer sold 9,593 shares at $2.31 ($22,184)
- 4 Planned sale Chief Scientific Officer sold 9,982 shares at $2.31 ($23,083)
- 4 Planned sale Interim President & CEO sold 10,164 shares at $2.31 ($23,504)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Business Officer acquired 83,700 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 82,200 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 79,000 shares (grant or award)
Page 3 of 14 · 274 filings